Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,788.80
(
0.70%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
104.51
(
0.31%
)
Bitcoin
80,951.74
(
-0.13%
)
News Focus
News Focus
Post# of 826144
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

XMaster2023

Send PM Follow Ignore
Followers 21
Posts 2552
Boards Moderated 0
Alias Born 06/24/2023

XMaster2023

Re: HyGro post# 753686

Wednesday, 03/12/2025 12:20:11 AM

Wednesday, March 12, 2025 12:20:11 AM

Post# of 826144
The trial design is now antiquated, the end point (OS) is antiquated and the drug DCVax-L will not be used as a mono therapy. It’s an I dotted and T crossed because it was required for approval by MHRA. Think about it. Within 3 years, the game has changed. It’s amazing.
Bullish
Bullish
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News